Literature DB >> 2263879

Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats.

T Gasslander1, J Axelson, R Håkanson, I Ihse, I Lilja, J F Rehfeld.   

Abstract

Pancreaticobiliary diversion (PBD) caused a more than twofold increase in pancreatic weight after 10 days, with no further increase after 15 or 20 days or 7 weeks. Although the weight gain after PBD to a minor extent (10%) reflected increased water content, the main cause was hypertrophy and hyperplasia with increased pancreatic protein and DNA content. The cholecystokinin (CCK) concentrations in plasma were increased 10-fold from the 5th postoperative day. The trophic effects on the pancreas were completely abolished by the CCK antagonist L-364,718. Further, the antagonist caused a significant reduction in pancreatic weight, protein, and DNA in otherwise untreated controls. We conclude that PBD in rats induces trophic effects on the pancreas by increasing circulating CCK concentrations and that CCK is important for normal pancreatic growth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2263879     DOI: 10.3109/00365529008997635

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.

Authors:  J Axelson; B G Fan; B Ohlsson; J Rehfeld; M Ekelund; I Ihse
Journal:  Int J Pancreatol       Date:  1996-10

Review 2.  On the role of cholecystokinin in pancreatic cancer.

Authors:  M K Herrington; T E Adrian
Journal:  Int J Pancreatol       Date:  1995-04

3.  Effect of chronic oral administration of the CCK receptor antagonist loxiglumide on exocrine and endocrine pancreas in normal rats.

Authors:  I Imoto; M Yamamoto; D M Jia; M Otsuki
Journal:  Int J Pancreatol       Date:  1997-12

4.  Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.

Authors:  B Ohlsson; J Axelson; B Sternby; J F Rehfeld; I Ihse
Journal:  Int J Pancreatol       Date:  1995-08

5.  Postnatal development of circulating cholecystokinin and secretin, pancreatic growth, and exocrine function in guinea pigs.

Authors:  C S Joekel; M K Herrington; J A Vanderhoof; T E Adrian
Journal:  Int J Pancreatol       Date:  1993-02

6.  Profound duodenogastric reflux causes pancreatic growth in rats.

Authors:  T Gasslander; H Mukaida; M K Herrington; R A Hinder; T E Adrian
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

7.  The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.

Authors:  B Ohlsson; K Borg; J F Rehfeld; I Ihse; J Axelson
Journal:  Int J Pancreatol       Date:  1998-12

8.  Pancreatic hypertrophy with acinar cell nodules after longterm fundectomy in the rat.

Authors:  M Chu; L Franzén; S Sullivan; S Wingren; J F Rehfeld; K Borch
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

Review 9.  Experimental pancreatic hyperplasia and neoplasia: effects of dietary and surgical manipulation.

Authors:  P Watanapa; R C Williamson
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.